Vertaling van "august 3 conference call " (Nederlands → Frans) :

Pfizer Invites Public To View And Listen To Webcast Of August 3 Conference Call With Analysts
Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference

NEW YORK , N.Y. , June 29 - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, August 3, 2010.
NEW YORK, N.Y., November 3 - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Olivier Brandicourt, President and General Manager, Primary Care, at the 2010 Annual Credit Suisse Healthcare Conference on Wednesday, November 10, 2010 at 8:00 a.m.

Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.
Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.
Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com.

In 2000 the project launched a strategy of improving competence through the conference called Zelfmoordpreventie in Vlaanderen: van machteloosheid naar gerichte actie (Preventing suicide in Flanders: from helplessness to targeted action).
En 2000, le projet a lancé la stratégie du développement des compétences via la conférence « Zelfmoordpreventie in Vlaanderen: van machteloosheid naar gerichte actie? ».

On August 25, Novartis completed the acquisition of a further 52% stake in Alcon, Inc (Alcon) following on from the January 4, 2010 announcement that Novartis had exercised its call option to acquire Nestlé’s remaining 52% Alcon stake for approximately USD 28.3 billion or USD 180 per share.
Le 25 août, Novartis a achevé l’acquisition d’une participation supplémentaire de 52% dans Alcon, Inc (Alcon) à la suite de l’annonce faite le 4 janvier 2010 que Novartis avait exercé son option d’achat pour acquérir la participation restante de 52% détenue par Nestlé dans Alcon pour un montant d’USD 28,3 milliards environ ou d’USD 180 par action.